Authors
Nemanja Despot Marjanovic, Matan Hofree, Jason E Chan, David Canner, Katherine Wu, Marianna Trakala, Griffin G Hartmann, Olivia C Smith, Jonathan Y Kim, Kelly Victoria Evans, Anna Hudson, Orr Ashenberg, Caroline BM Porter, Alborz Bejnood, Ayshwarya Subramanian, Kenneth Pitter, Yan Yan, Toni Delorey, Devan R Phillips, Nisargbhai Shah, Ojasvi Chaudhary, Alexander Tsankov, Travis Hollmann, Natasha Rekhtman, Pierre P Massion, John T Poirier, Linas Mazutis, Ruifang Li, Joo-Hyeon Lee, Angelika Amon, Charles M Rudin, Tyler Jacks, Aviv Regev, Tuomas Tammela
Publication date
2020/8/10
Journal
Cancer cell
Volume
38
Issue
2
Pages
229-246. e13
Publisher
Elsevier
Description
Tumor evolution from a single cell into a malignant, heterogeneous tissue remains poorly understood. Here, we profile single-cell transcriptomes of genetically engineered mouse lung tumors at seven stages, from pre-neoplastic hyperplasia to adenocarcinoma. The diversity of transcriptional states increases over time and is reproducible across tumors and mice. Cancer cells progressively adopt alternate lineage identities, computationally predicted to be mediated through a common transitional, high-plasticity cell state (HPCS). Accordingly, HPCS cells prospectively isolated from mouse tumors and human patient-derived xenografts display high capacity for differentiation and proliferation. The HPCS program is associated with poor survival across human cancers and demonstrates chemoresistance in mice. Our study reveals a central principle underpinning intra-tumoral heterogeneity and motivates therapeutic …
Total citations
202020212022202320241260758142
Scholar articles